Novartis to go live with blockchain network in 2020

Last week, the heads of blockchain for Novartis revealed that they plan to implement the technology throughout the business. Appearing on CNN, Marco Cuomo and Daniel Fritz shared the use cases and challenges of blockchain in pharmaceuticals. Ledger Insights interviewed Cuomo and Fritz last year when Novartis was mainly working on its Innovative Medicines Initiative  (IMI) partnership. The two also introduced how the firm filters out use cases which aren’t suited to blockchain.

Credentialing for pharma

Has anything changed in the last year? While IMI, the world’s largest public-private program for health investments, is still a priority, Novartis is now developing solutions in credentials and automation. “We are very focused on verifiable credentials,” said Cuomo. “Everywhere you need a stamp to approve something, we could improve that with something more digital, machine-readable, and improve some areas in supply chain and some areas in clinical trials.”

Article continues …

---